Stocks such as Oracle and Micron Technology are among several growth plays left in a market that recently soared to records.
How to play a potential biotech breakout in 2025 with options
Nishant Pant gives a bullish call spread trade on the iShares Biotechnology ETF.
UBS says buy Manchester United shares: ‘Red Devils set to rise again’
A turning point in Manchester United’s performance could kick off some upside for shares, according to UBS.
Mizuho upgrades Tesla to buy, citing ‘idiosyncratic tailwinds’ over next four years
The firm thinks Tesla is better-positioned relative to its peers given the prospect of favorable regulation under the Trump administration.
Goldman Sachs double upgrades this solar stock, says 2025 will mark a major turnaround
SolarEdge Technologies is in the early stages of making a strong recovery, according to Goldman Sachs.
Morgan Stanley says buy this digital health stock poised to rally more than 50%
Growth in Hims & Hers Health is showing no signs of stopping, according to Morgan Stanley.
Tuesday’s big stock stories: What’s likely to move the market in the next trading session
The Nasdaq Composite posted a fresh closing record. The Dow, however, fell for an eighth day. Here’s what’s on CNBC’s radar going into Tuesday.
‘Tis the season for small caps starting right now, says BTIG
Small-cap stocks typically perform well over the next two months, even relative to their larger peers, according to a BTIG strategist.
How to invest $50,000 in 2025 to generate safe income
Investors who want to earn some interest on idle cash can still do just that in the new year.
These stocks are still a bargain relative to the expensive S&P 500
There are still stock market bargains to be found heading into 2025, despite the S&P 500’s lofty valuation.